Brain Tumor Therapeutics Market Forecast 2025-2030: A $5.28 Billion Industry Opportunity with Projections by Type, Therapy, Patient Age Group, Distribution Channel, End-user and Region

Dublin, Nov. 28, 2024 (GLOBE NEWSWIRE) — The “Brain Tumor Therapeutics Market by Type, Therapy, Patient Age Group, Distribution Channel, End-User – Global Forecast 2025-2030” report has been added to ResearchAndMarkets.com’s offering.

The Brain Tumor Therapeutics Market grew from USD 3.03 billion in 2023 to USD 3.28 billion in 2024. It is expected to continue growing at a CAGR of 8.24%, reaching USD 5.28 billion by 2030.

The report provides a detailed overview of the market, exploring several key areas:

1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Market growth is significantly influenced by advances in healthcare technologies, increasing incidences of brain tumors, and heightened investment in oncology research. The latest potential opportunities lie in personalized medicine, genomics, and the development of novel drug delivery systems, such as nanoparticle-based therapeutics. Companies are recommended to invest in partnerships and collaborations with research institutes to access cutting-edge innovations and to leverage AI and machine learning for research and development.

Limitations in this market include high R&D costs, regulatory hurdles, and the complex biology of brain tumors which often complicates treatment efficacy. Additionally, regional disparities in healthcare infrastructure can pose challenges to broader access. Innovations should focus on non-invasive treatment options and precision medicine approaches, such as biomarkers for early detection and assessment of treatment response. Meanwhile, research into immunotherapy and the development of blood-brain barrier-penetrating drugs holds promise for business growth.

The nature of the market is highly competitive and rapidly evolving, necessitating proactive adaptation and strategic investment to capture emerging trends and maximize market share. Overall, there’s a robust demand and opportunity in fostering integrated treatment paradigms that offer comprehensive care and enhanced patient outcomes.

Brain Tumor Therapeutics Market Dynamics

• Market Drivers
  • Rising incidences of brain cancer and other neurological disorders
  • Rising need for tests detecting the presence of tumors
  • Research activities in the molecular diagnostics
• Market Restraints
  • High cost associated with the diagnosis and treatment
• Market Opportunities
  • Rising healthcare expenditure and favorable reimbursement policies
  • Government initiatives for cancer awareness
• Market Challenges
  • Side effects associated with brain tumor therapeutics

Key Company Profiles

The report delves into recent significant developments in the Brain Tumor Therapeutics Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Adcendo ApS, AIVITA Biomedical, Inc., Amgen Inc., AstraZeneca PLC, Aura Biosciences, Inc., Bayer AG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bristol-Myers Squibb Company, CNS Pharmaceuticals, Inc., Curtana Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Eisai Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, GE HealthCare Technologies Inc., Gentech, Inc., GlaxoSmithKline PLC, Illumina, Inc., Johnson & Johnson Services, Inc., Merck & Co. Inc., Merck KGaA, Novartis AG, Novocure GmbH, Pfizer Inc., Qiagen N.V., Sanofi S.A., Siemens Healthcare GmbH, and Y-mAbs Therapeutics, Inc.

The report addresses key questions to assist stakeholders in making informed decisions:

1. What is the current size of the market, and how is it expected to grow?
2. Which products, segments, and regions present the most attractive investment opportunities?
3. What are the prevailing technology trends and regulatory factors influencing the market?
4. How do top vendors rank regarding market share and competitive positioning?
5. What revenue sources and strategic opportunities guide vendors’ market entry or exit decisions?

Key Attributes

Key Topics Covered

1. Preface

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Brain Tumor Therapeutics Market, by Type
6.1. Introduction
6.2. Glioblastoma
6.3. Meningioma
6.4. Metastatic Brain Tumors
6.5. Pituitary Tumors

7. Brain Tumor Therapeutics Market, by Therapy
7.1. Introduction
7.2. Chemotherapy
7.3. Gene Therapy
7.4. Immunotherapy
7.5. Radiation Therapy
7.6. Targeted Therapy
7.7. Tissue Engineering

8. Brain Tumor Therapeutics Market, by Patient Age Group
8.1. Introduction
8.2. Adult
8.3. Pediatric

9. Brain Tumor Therapeutics Market, by Distribution Channel
9.1. Introduction
9.2. Offline Pharmacies
9.3. Online Pharmacies

10. Brain Tumor Therapeutics Market, by End-User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Hospitals
10.4. Specialty Clinics

11. Americas Brain Tumor Therapeutics Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Brain Tumor Therapeutics Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Brain Tumor Therapeutics Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.4. Strategy Analysis & Recommendation

For more information about this report visit https://www.researchandmarkets.com/r/ne0j55

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

• Brain Tumor Therapeutics Market